SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " RAS " 5,445 found 🔀 AI-powered Shuffle
Anthropic's Mythos 5 gets limited carveout from US restrictions
Anthropic said it is restoring access to Mythos 5 for a set of US organizations that "operate and defend critical infrastructure."
What Apple Just Confirmed About the iPhone 18 Pro and Ultra
Apple has confirmed the foldable iPhone Ultra and iPhone 18 Pro for fall 2026. Explore the new A20 Pro chip, variable aperture cameras, and premium designs.
Scratching that bug bite might feel good at first but science explains why it’s a bad idea
WASHINGTON (AP) — You’ve likely heard it since childhood: Don’t scratch that bug bite or rash, you’ll make it worse. But why would something that feels so good be bad? A lot of things can cause itc…
Scratching that bug bite might feel good at first but science explains why it's a bad idea
You’ve likely heard it since childhood: Don’t scratch that bug bite or rash, you’ll make it worse. A lot of things can cause itchiness, sometimes serious diseases. Whatever the cause, doctors have l...
Arsenal hold talks with Strasbourg technical director Pascal de Maesschalck
Arsenal have held talks with the technical director of RC Strasbourg Alsace, Pascal de Maesschalck, according to a report from The Athletic.The Premier League champions are in the process of finding ...
Driving A New Ford Mustang Mach-E After 5 Years Feels So Much Better
The 2026 Ford Mustang Mach-E isn't drastically different from its original 2021 version, but small improvements and a price dip make it a better EV purchase.
Meet a scientist tracking invasive reptiles, and even their parasites
An insider's look at Florida’s war on invaders: the giant snakes, egg-eating predators and parasites spreading through the Everglades.
State Street Eating House owner wins women-owned business award at Sarasota ceremony
Owner says she was unprepared for the recognition at the Frank G. Berlin, Sr. Sarasota Business Awards.
NFL stadiums swapped turf for grass ahead of 2026 World Cup. George Kittle thumping for permanent change: 'Clearly we know it's possible'
Presidential ambitions? Moore speech to contrast Trump rally
Wes Moore has repeatedly said he's focused on his role as governor, but political analysts say his actions point to a run for higher office.
We almost had a smartphone in the 90s. Why did it fail?
In the early 90’s, a company called General Magic began working on a portable device that would allow people to check email, make phone calls, even play games. It was basically a smartphone. But it never caught on.On today’s show, a theory about why this device failed. General Magic had generous investors, world-class talent and creative freedom. But is it possible what they needed was constraints?Support:Planet Money+Read: Our book: Planet Money: A Guide to the Economic Forces That Shape Your Life Our weekly longform Planet Money newsletterOur weekly Indicator round-up newsletterFollow: InstagramTikTokYouTubeFacebookThis episode was hosted by Erika Beras and Emma Peaslee. It was produced by Emma Peaslee with help from Sam Yellowhorse Kesler and James Sneed. It was edited by Marianne McCune and fact-checked by Charlotte Isidore. It was engineered by Jimmy Keeley with help from Cena Loffredo. Alex Goldmark is Planet Money’s executive producer.
His Fortune’s From the Trash Business. His Basquiats Are Priceless.
In the last few years, waste-management billionaire Patrick Dovigi has become one of the biggest art collectors on the scene. But he’s still under the radar—maybe the shots fired on his home have something to do with that.
$13 million in federal funding to be distributed across West Michigan clinics
More than $13 million in federal funding will be distributed across West Michigan hospital and clinic systems for research projects and healthcare infrastructure.
Nebraska Hispanic Chamber of Commerce holds networking event for Omaha businesses
Watch: Omaha business leaders met at Mexico's consulate to network with the Nebraska Hispanic Chamber of Commerce
CBS Sports speculates that Colts’ star could be ‘one of five players to force trade’
Could Colts running back Jonathan Taylor eventually request a trade from Indianapolis?
How to Keep Your Skin Healthy and Hydrated in Summer Months
From sunburns to heat rashes, board-certified Dr. Angela Lamb joins TODAY with solutions for common summer skin problems.
Business Leader Tim Giroux Announces Candidacy for Nevada Joint Union High School District Trustee
GRASS VALLEY, Calif. – June 26, 2026 – Tim Giroux, a business leader and community member rooted in the Auburn/Grass Valley area since 1999, today announced his candidacy for Trustee of the Nevada Joint Union High School District. The election will be held in November 2026. Giroux brings more than 40 years of business ownership […]
Warren Buffett Bought A Business For $1.7B ‘Over The Phone Without Ever Meeting The People There’ Using The ‘Most Valuable Skill’ He Learned
Buying a company for $1.7 billion without meeting management sounds like the kind of decision that would keep lawyers busy for months. Warren Buffett did it over the phone. Speaking at the University of Nebraska-Lincoln in 2003, Berkshire Hathaway Chair...
Starlink veterans launch startup to broaden megaconstellation ownership
Former SpaceX engineers who helped build and scale Starlink have launched a startup aiming to deliver megaconstellations for governments and companies seeking more control over space-based infrastructure.
Trump forced to drain the reflecting pool swamp
Jonathan Freedland speaks to Arwa Mahdawi about why this project is proving to be such an embarrassing failure for the president
Parasite Affecting 1 in 3 People Is a Serious Risk to Human Health, Scientists Warn
More needs to be done.
What we learned as Bryce Harper caps Phillies' shocking comeback trilogy
The Phillies erased another five-run deficit, rallied late again and reached the season’s halfway point with another reminder of how much has changed.
Matt Rhule hosts youth football camp in Omaha through FlexWork Sports
Matt Rhule and four Nebraska football players made the trek to Omaha Thursday.
Digital-Only 'Grand Theft Auto VI' Is a Car Crash for Physical Media
Not all progress is progress.
Michigan president has strong words for college sports after Dusty May exit
Michigan president Domenico Grasso spoke with Dusty May and said he cited the transfer portal and uncertainty about NIL as reasons for his departure.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Impact of European heat wave on transportation, businesses, tourism
A heat wave across Europe caused record-breaking temperatures, affecting businesses, infrastructure, and daily life.
Original 'Drag Race' star reportedly hospitalized in critical condition after fatal car crash
'RuPaul's Drag Race' season 1 queen David 'Jade' Sotomayor reportedly hospitalized after a fatal car crash in Chicago, with Monica Beverly Hillz telling EW she wants fans to send the family 'good vibes.'
Sean Hannity Explains Puffy Face in Health Update Amid Viewer Concern
Sean Hannity gave a health update after viewers expressed concern about his puffy face and raspy voice in recent Fox News telecasts.
Samsung’s new budget phone costs $50 more despite downgrades
The Galaxy A27 has a new chip, but worse waterproofing and lower resolution cameras than its predecessor.
Mets commit six infield errors in embarrassing loss to Cubs: 'This team is in the depths of despair'
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Bologna open talks for Rangers' Raskin
Rangers midfielder attracts interest from Italy and England and Scotland goalkeeper could land move to Premier League giants...
Fox News Star Sean Hannity Addresses Health Diagnosis After Viewer Concerns Over "Raspy Voice And A Puffy Face"
Fox News Star Sean Hannity Addresses Health Diagnosis After Viewer Concerns Over "Raspy Voice And A Puffy Face"
4 charged in Nebraska as part of DOJ national health care fraud takedown
Criminal charges announced today are tied to alleged schemes to defraud Medicare and Medicaid, according to the U.S. Attorney’s Office for the District of Nebraska.
South Korea juggles digital sovereignty and alliance politics
South Korea’s closest allies are increasingly challenging its control over digital platforms, data and technological infrastructure.
iOS 27 Home App: 10+ New HomeKit Features
Apple updated the Home app with some useful new features that rely on Apple Intelligence. The updates improve the way HomeKit Secure Video cameras work on Apple's HomeKit platform. Apple Intelligence Summaries The Home app generates written summaries for motion alerts and what's detected, using AI to determine what's been recorded.
Tooting its own horn: Keller business with brass focus proves its mettle
Houghton Horns has been providing horn repair, service and supplies for 40 years.
Exclusive: Trase raises $107M for health care and defense AI
The company will be in market later this year for a round projected to be in the "hundreds of millions."
Micron forecasts quarterly revenue above estimates
Micron Technology forecast quarterly revenue above Wall Street estimates on Wednesday, signaling that insatiable demand for AI-related infrastructure will continue to drive strong demand for its memory chips.
Overwatch Fans Revolt Over New Skins That Cost Too Damn Much
The new ‘Ultra’ skins include visual and audio effects, but is that enough?
QED Science Launches AI Infrastructure for Scientific Validation
Recognizes The 1% After Blind Evaluation of 57,455 Scientific PreprintsTEL AVIV, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- QED Science, a science validity engine and modern infrastructure for researchers, funders, institutions and life science organizations today launched The 1%, the top 574 life science preprints. The company anonymously scored 57,455 bioRxiv preprints submitted between May 2025 and April 2026 for originality and validity. The ranking is powered by QED Score, QED Science’s vali
How Colombia’s traditional midwives serve as lifelines to rural communities
Parts of Colombia are isolated, with no hospitals nearby. Experts say midwives can help bridge the healthcare gap.
A retro outdoor food park and entertainment venue is coming to Seminole Heights this fall
A slice of Old Florida could be coming to Seminole Heights this fall. Developers last week announced plans for Nebraska Roadside, an open-air food park and
Rejuvenating politics and delivering on promises of equality and participation: milestone event in Strasbourg
Young people are shaping the New Democratic Pact for Europe
QED Science Launches AI Infrastructure for Scientific Validation
QED Science Recognizes The 1% and Launches AI Infrastructure for Scientific Validation ...
Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States
/PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a strategic partnership with Ouma Health,...
AMC Entertainment Crashes 23% Upon Sell of 95.25 Million Shares to Raise $200 Million In Capital
AMC Entertainment stock moves after announcing a 95.25M share offering to raise $200M, primarily to retire its remaining 2027 debt maturity ahead of schedule.
Knicks Fan Who Stole Trash Can Identified, Fired From Job
The New York Knicks fan who went viral last week for appearing to steal a Knicks-themed trash can during the team's NBA Finals parade has reportedly been identified and fired. Last week, as the New York Knicks held their NBA Finals championship parade, the city brought out special orange-and-blue, ...
Health Beat: Parasitic fly outbreak prompts Pa. to restrict animal movement
New World Screwworm is a parasitic fly that feeds on the flesh of warm-blooded animals and people and then can lay eggs in the wounds.
What the Reflecting Pool debacle says about Trump and his presidency
The contrast from what Trump promised in April, when he announced his plan to repair and refurbish the pool, has been nightmarish.
Project ASCENT at ILL selected for EU funding under "Choose Europe for Science"
The Institut Laue-Langevin (ILL) will lead the ASCENT project, funded at 1.4 M€ by the European Commission as part of the initiative "Choose Europe for Science 2025". The goal is to train the next generation of researchers and sustain Europe’s leadership in neutron science. ASCENT is one of 16 projects (three of them in France) funded under the pilot call of a programme that aims to enhance the attractiveness of research careers in Europe and address the challenge of scientific talent retention. It is also the only project led by a large-scale infrastructure.
Roku May Help Fox Avoid Aggregeddon
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Scrolling through links over the last week, I stumbled across this fun headline: Wow. Formula 1 (the sport, not the docu-series) is the perfect “dog not barking”. As a reminder, each week in my Streaming Ratings Report, I call out the shows that miss every viewership chart. I dub them “dogs not barking”—like the Sherlock Holmes mystery—because without any data, we forget they even exist. This is in contrast to something like, say, a film flop—cough The Mandalorian and Grogu cough—where even underperforming at the box office is widely discussed here, there and everywhere. In the US, Formula 1 is now in “no public viewership data, so not discussed” territory. After moving to Apple TV from its former home of ESPN, basically no one talks about it. Apple did publish an initial, unsourced, unsubstantiated, (dare I say unserious) datecdote claiming more folks are watching Formula 1 on Apple than ESPN, but we haven’t gotten any updates since. This stands in contrast to when the sport streamed on ESPN, and ESPN PR provided weekly viewership figures. Formula 1 was, at best, a niche sport in America—averaging 1.3 million viewers in the Big Data Plus era—but now it’s basically anonymous. (And yeah, after moving to Apple, I very, very, very much doubt its ratings increased.) Unfortunately, that story isn’t quite big enough to warrant a section in today’s “Most Important Story of the Week” column, but I wanted to call it out, because otherwise, no one else will! Certainly, no one will write articles about the silence/ratings decline, unlike when they wrote breathless articles connecting the rise in viewership to Netflix’s Drive to Survive, including Reuters just last month. (This is a topic I’ve tried to provide a moderate/nuanced/non-hyped take since 2022.) Anyway, on to this week’s issue. I was a bit worried I didn’t have a juicy topic, then the Murdochs went out and did their Murdoch thing: buying Roku. So that’s the story of the week, and it happens to touch on quite a few themes of the streaming wars and the disruption therein. I’ll cover that, plus why more consolidation in Hollywood media looks likely, more good news on the Hollywood labor front, whether we’ll see an uptick in production in Los Angeles, some Broadway and theme park news, cellphone prices going up in the third world (and possibly everywhere), and more. Subscribe Most Important Story of the Week - Another Big Media & Entertainment Merger The story of the week is clearly Fox is buying Roku for $22 billion. I read a lot of good strategy takes on why Fox bought this streaming TV device maker—and I’ll have mine below—but what fascinates me more is how this deal connects to quite a few themes of the streaming wars, linking to everything from the pace of M&A to “aggregeddon” to Netflix’s recent M&A actions/inactions to the shift to advertising from pure play streaming and more. The only topic I can’t really connect it to is my old theory, “never bet against Rupert Murdoch” because he isn’t the one who did this deal; his son Lachlan inked it. (Do I think he provided advice, even at his 95 years of age? Sure.) That plus I have one additional piece of strategy for all entertainment players, inspired by this deal. So let’s dive into all those topics, starting with why I like this deal. Roku is a Great M&A Buy
Judge strikes down SNAP restrictions on soda and other items in 5 states
The judge said that her order applied to the programs in Colorado, Iowa, Nebraska, Tennessee and West Virginia
1 hurt after vehicle hits Dayton business
The crash was reported shortly after 10:30 a.m. on W. Third Street.
Louisiana Rastafarian man can’t sue staff who shaved his dreadlocks, Supreme Court says
Courts have largely agreed that the man’s religious rights were violated, but have said the law doesn’t allow him to sue state prison officials.
Supreme Court rules against Rastafarian who sued prison officials for cutting his dreadlocks
The Supreme Court on Tuesday ruled that a devout Rastafarian who attempted to sue prison officials for cutting his dreadlocks could not proceed with his case, a decision that will likely make it harder for believers of other faiths to enforce federal religious protections in prison.
Yankees Rivalry Roundup: Royals’ Wacha outduels Rays’ Rasmussen
Recapping how the Yankees’ top AL opponents fared on June 22nd.
The best Prime Day Lego deals include 'Star Wars' ships, Disney villain cars, and more — top finds start at $28
Lego fans can save big during Amazon Prime Day, with deals on “Harry Potter,” “Star Wars,” Lego Technic, and Ninjago sets, plus builds inspired by Marvel, Disney, “Jurassic World,” Minecraft, Formula 1 racing, and more. We've rounded up Prime Day’s 17 best Lego deals, including several at their lowest prices ever
Markets Recoil in Global Sell-Off Driven by Tech Stocks
Chipmakers led the way down in South Korea, where the main index crashed 10 percent. Stocks in Europe were lower and S&P 500 futures pointed to a sharp fall.
Listening for quantum oscillations in the Kondo insulator YbB12
Magnetic quantum oscillations have been unexpectedly observed in insulators, where freely moving charge carriers are not expected to exist. A joint study by researchers from Tokyo University of Science, The University of Tokyo, and Kobe University investigated this puzzling behavior in the Kondo insulator YbB12 using ultrasound. While no oscillations were detected in the insulating state, clear signals emerged after the material became metallic, offering new insight into unusual quantum behavior in next-generation materials.
Federal judge halts Trump administration effort to subpoena Walz in immigration enforcement probe
A federal judge has blocked an attempt by the Trump administration to subpoena Minnesota Gov. Tim Walz and other state officials, calling it an effort to “harass and retaliate against them.”
Two injured after vehicle crashes into Richland Township business
Two people were taken to the hospital after a vehicle crashed into a business along Scalp Avenue in Richland Township late Monday morning.According to emergency
Can America’s data center backlash stay bipartisan?
Opposition spans party lines as communities resist AI infrastructure's impact on energy costs and resources.
Mobile health tops early RHTP funding trends
State rural health transformation programs aim to overcome high startup costs and allow rural providers to deliver complex care locally with remote ultrasound, RPM and other mobile health technologies, says one industry expert.
NAIRR Science Program Reshapes Scientific Research, Powered by NVIDIA AI Infrastructure
The U.S. National Science Foundation’s NAIRR pilot program has driven innovative research across the U.S. for over 700 projects — spanning protein prediction and infectious disease outbreak management.
Politician behind 'top two' primary has second thoughts
The man who brought California the top-two open primary now thinks it needs a drastic overhaul.
DOJ may be able to release potentially embarrassing Biden audio recordings unless courts step in
Former President Joe Biden is in an uphill battle to try to stop the Justice Department from sharing recordings it collected of him speaking to his ghostwriter in 2016 and 2017, during which his speech and memory faltered.
‘Founder’ Is the New Brass Ring for Computer Science Grads
The share of employed 2025 CS graduates with the title doubled in a study of 20 universities with renowned tech programs.
Inspired by Eastern Iowa, Dave Rasdal pens novel ‘Clayville’
Former Cedar Rapids Gazette "Ramblin'" columnist Dave Rasdal, 73, discusses his new novel "Clayville," which was inspired by his 30-plus-year journalism career and the small towns around Eastern Iowa.
Ubisoft co-founder Claude Guillemot has died in a plane crash
The French businessman was 69 years old
America’s data center backlash is bipartisan — can it stay that way?
As opposition mounts, some experts wonder how long AI infrastructure can steer clear of the partisanship that defines U.S. politics.
Technological Decolonization in the Shadow of Algorithmic Hegemony
With every crisis originating from a tech company, we see a fresh batch of dirty laundry aired & we fail to grasp the scale of the issue.
Apple's first Ultras are coming: 20 new products in 2026–2027 according to Bloomberg
Apple's new CEO John Ternus will begin his tenure in September with a wave of new products that will bring Apple fans many exciting new releases. Well-known Bloomberg analyst Mark Gurman has listed the most important new products coming our way after the summer break, including the first ones potentially bearing the “Ultra” moniker.
Tesla driver on auto assistance crashed into Texas home, kills woman
It was not clear which of Tesla's features the driver was using at the time of the crash.
Scientists Discover Strange Horn-Shaped 'Hyperparasite', a World First
It preys on 'zombie fungus'.
Yashica's New Keychain Camera Has A Flip Screen And Costs Under $30
If you're enjoying other retro cameras that are currently on the market, Yashica has a new micro version that is just small enough to fit on a key ring.
A cloud-based miniscope for neurosurveillance of brain health and disease in freely behaving animals
Nature Methods - A miniscope with cloud-based operation and multicontrast capabilities enables continuous recording of neuronal activity, hemodynamics or cellular dynamics over multiple days. This...
The twisted science and traps in framing Notre Dame’s best QBs of the past 50 years
Comparing Notre Dame QBs across eras isn't easy. Stats, titles and context all complicate the debate as CJ Carr begins building his legacy.
Ubisoft co-founder Claude Guillemot dies in plane crash
Guillemot was one of two people killed in the accident on 19th June in Brittany, France, after the twin-engine plane – registered to Guillemot – crashed.
Ubisoft co-founder Claude Guillemot dies in plane crash
Claude Guillemot, who founded Ubisoft with his four brothers, has died at the age of 69.
Nebraska Cornhuskers unveil new uniforms for 2026 season
The Nebraska Cornhuskers are unveiling new uniforms for the 2026 college football season, they announced on Saturday.
Dirty politics, dirty soda and dirty Mormon wives
A young neighbor's entrepreneurial enterprise leads to an astounding television show that helps explain our national morass.
10 Walmart Gadgets Under $50 That Are Actually Worth Buying
You can get high-quality security cameras, Bluetooth speakers, Nintendo Switch controllers, and many other tech gadgets for under $50 at Walmart.
Every Nebraska player drafted by the Boston Celtics
Let's take a look at every player who has been drafted by the Celtics out of Nebraska.
Driver fleeing from police crashes into South Side business
A man wanted for robbery and domestic violence fled from police Saturday evening, crashed his vehicle into a business and then escaped pursuing officers...
Electric bike and scooter injuries surge in Iowa, UnityPoint Health reports
In 2020, UnityPoint reported just 16 crash-related emergency room visits. This year alone, that number has already reached 79.
One common fat may fuel type 2 diabetes while another helps fight it
Not all fats affect your body the same way. Researchers found that palmitic acid, a saturated fat common in many foods, may contribute to insulin resistance and type 2 diabetes by triggering inflammation, toxic fat buildup, and cellular stress. In contrast, oleic acid—the heart-healthy fat abundant in olive oil—appears to help protect insulin function and may even counter some of the harmful effects of palmitic acid.
Trump wanted out of the Iran war. The aftermath is pulling him back in.
The ceasefire reopened diplomacy, but it also left Washington to manage Iran’s leverage, Israel’s attacks and a MAGA backlash.
Suspect flees on foot after crashing into Pittsburgh business during pursuit
Suspect fleeing officers crashes into Pittsburgh business & gets away on foot, police say
The man was wanted on felony charges of robbery and domestic violence.
Suspect flees on foot after crashing into Pittsburgh business during police pursuit
A suspect with felony warrants is wanted after Pittsburgh police say he fled from officers, crashed into a business, and escaped on foot.
UH researchers awarded $12M grant to advance AI, data science in medicine | University of Hawaiʻi System News
New center will support innovative biomedical research, develop future scientific leaders, and expand research infrastructure in Hawaiʻi.
Rossini opera next up at Winter Harbor Music Festival
One of the most beloved operas of the bel canto repertoire, Gioachino Rossini’s “L’italiana in Algeri” (Italian Girl in Algiers), will be the first opera presented in the Winter Harbor
Claude Guillemot, Ubisoft Co-Founder, Is Dead After Plane Crash in France
Claude Guillemot, 69, founded the video game company, which was also known for the hit Far Cry, with his brothers in 1986. He was killed in western France.
Ubisoft co-founder Claude Guillemot killed in plane crash that claimed 2 lives: report
Claude Guillemot, one of the five brothers who founded Ubisoft in 1986, reportedly died in a twin-engine plane crash in La Baule, France.
Ubisoft co-founder Claude Guillemot killed in plane crash that claimed 2 lives: report
Claude Guillemot, one of the five brothers who founded Ubisoft in 1986, reportedly died in a twin-engine plane crash in La Baule, France.
Co-founder of ‘Assassin’s Creed’ video game giant dies in plane crash
Ubisoft co-founder Claude Guillemot, 69, died in the crash on France’s Atlantic coast along with another occupant of a twin-engine Cessna 421.